R&D
Reuters Pharma USA 2024 – Meruno Perugini
Innovation in pharma comes in many forms, but at the end of the day what the industry cares about is results.
Patients
Spotlight on kidney disease: Driving change for patients
Katherine Forbes, director of innovation and enterprise at Kidney Research UK, discusses the unique, evolving role of medical research charities in facilitating collaborative partnerships a
Market Access
Deep Dive: Market Access 2024
In this edition of Deep Dive, Unpacking complex choreography in the biologics patent dance, Alexion examines the urgent need for accelerated access programmes for rare disease treatments, and Putna
R&D
Is precision psychiatry possible?
Anyone who has taken a psychiatric medication knows that the status quo in prescribing is a trial and error approach, with patients often cycling through an array of drugs to find the one t
R&D
Emergence of ADCs as the “hot, new technology”
The recent acquisition of ImmunoGen by AbbVie, which followed the earlier acquisition of Seagen by Pfizer, has brought renewed attention to antibody-drug conjugates (ADCs), highlighting the
Editor's Picks
Editor's Picks
